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Abstract 
 
Ribotoxins are a family of toxic extracellular fungal RNases that first enter 
into the cells and then exert a highly specific ribonucleolytic activity on the larger 
rRNA molecule, leading to protein synthesis inhibition and cell death by 
apoptosis. α-Sarcin is the best characterized ribotoxin. Previous 
characterization of a deletion variant of this protein showed that its long NH2-
terminal β-hairpin is essential for its cytotoxicity. Docking, enzymatic, and lipid-
protein interaction studies suggested that this β-hairpin establishes specific 
interactions with ribosomal proteins and that it is a region involved in the 
interaction with cell membranes. Consequently, in order to assess the influence 
of the basic character of this NH2-terminal β-hairpin (there are 1 arginine and 4 
lysines along its 16 residues) on the ribotoxins cytotoxic ability, five individual 
mutants substituting these 5 basic residues by glutamic acid were produced, 
purified to homogeneity, and characterized. Regarding ribosomal recognition, all 
mutants showed a diminished activity in a cell-free reticulocyte lysate, whereas 
the activity against an oligoribonucleotide mimicking the sarcin/ricin loop rRNA 
(SRL) or the homopolymer poly(A) remained unaffected, confirming that the 
mutated basic residues participate in electrostatic interactions with other 
ribosomal elements apart from this SRL. The study of the interaction with 
phospholipid vesicles showed that Lys 17, Arg 22, and, most importantly, Lys 
14 and Lys 21, are crucial residues in the first stages of the aggregation 
phenomenon, where protein-vesicle and protein-protein interactions are 
required. The data obtained reveal that electrostatic interactions involving basic 
residues of the β-hairpin are required not only for establishing specific 
interactions with ribosomal regions other than the SRL but also to explain the 
ability of the protein to interact with acid phospholipid bilayers. 
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Introduction 
 
α-Sarcin is the most representative member of ribotoxins, a family of 
fungal natural killers characterized by their exquisite ribonucleolytic specificity 
against ribosomes and their ability to cross cellular membranes in the absence 
of any known protein receptor [1,2]. These toxic proteins cleave just a single 
phosphodiester bond of the large rRNA fragment, located at an evolutionarily 
conserved loop with important roles in ribosome function [3-5]. This cleavage 
inhibits protein biosynthesis, leading to cell death by apoptosis [6]. This 
important region has become to be known as the sarcin/ricin loop (SRL) 
because it is not only the target of α-sarcin and the rest of ribotoxins but also of 
the much larger group of plant ribosome-inactivating proteins (RIP), best 
represented by ricin [7,8]. 
Most ribotoxins show a high degree of sequence identity [9-12] that is 
also manifested in the three-dimensional structure of the two only ribotoxins 
studied at this level, restrictocin [13,14] and α-sarcin [15-18]. Both proteins fold 
into an α+β structure with a central five-stranded antiparallel β-sheet and an α-
helix of almost three turns and display long and unstructured loops (Fig.1) 
[15,19,20]. Residues 1–26 form a long NH2-terminal β-hairpin that can be 
considered as two consecutive minor β-hairpins connected by a hinge region 
with its most distal part jutting out as a solvent exposed protuberance (Fig. 1). 
This β-hairpin is one of the regions showing the highest sequence variability 
among ribotoxins [9-12,21]. An α-sarcin mutant involving the deletion of this 
protuberance, α-sarcin Δ(7–22), retained the same conformation as the wild-
type protein, as ascertained from its three-dimensional structure in solution [22]. 
However, functional and enzymatic studies revealed that this mutant exhibited 
ribonuclease activity against naked rRNA and synthetic substrates but lacked 
the ability to specifically cleave the SRL in intact ribosomes [23]. These results 
were explained by in silico studies that predicted how this NH2-terminal β-
hairpin could establish essential interactions, mostly of electrostatic nature, with 
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specific ribosomal proteins in order to direct the ribotoxin to the SRL region of 
the ribosome [18]. 
In addition to their specific and lethal ribonucleolytic activity, ribotoxins 
can also cross phospholipid membranes due to their ability to interact with acid 
phospholipid-containing bilayers [6,24-28]. This is the basis to explain why they 
are especially active on transformed or virus-infected cells [6,29,30], although 
any ribosome could be potentially inactivated by them, given the universal 
conservativeness of the SRL. According to the current model accepted to 
explain the ability of α-sarcin to interact with phospholipid bilayers, the protein 
would be initially adsorbed to the charged polar head groups of the 
phospholipids, and then would partially penetrate the interface of the bilayer to 
interact with a portion of the lipid hydrocarbon chains [1,6,26,31,32]. This 
intercalation within the lipid matrix would promote fusion and permeability 
changes in the bilayers, processes that would presumably be involved in the 
passage of the protein across the membrane of its target cells. Two regions of 
the protein, located at opposite ends of the protein molecule, have been 
proposed to be specifically involved in vesicle aggregation [33]. These regions 
would be loop 2 and, again, the NH2-terminal β-hairpin (Fig. 1), which 
consequently would also participate in the interaction with cell membranes. In 
good accordance with this proposal, the α-sarcin Δ(7–22) mutant also displayed 
a diminished ability to interact with phospholipid lipid vesicles showing a 
behavior compatible with the absence of one vesicle-interacting region [23]. In 
agreement with all these conclusions, the deletion mutant exhibited a very low 
cytotoxicity on human rhabdomyosarcoma cells [23]. 
α-Sarcin is a highly charged protein, with a high isoelectric point [34;,35]. 
This high content of positively charged residues, mostly located at the loops and 
the NH2-terminal β-hairpin, is probably required for recognizing and binding not 
only to its highly negatively charged target, the SRL rRNA, but also to ribosomal 
proteins and cellular membranes [18,36, 37]. In this context, the role of the 
positively charged residues located at the NH2-terminal β-hairpin (Table 1) in 
these different but closely related events has been studied in the work herein 
presented. 
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Materials and methods 
 
DNA manipulations 
 
All materials and reagents were of molecular biology grade. Cloning 
procedures, oligonucleotide site-directed mutagenesis, and bacterial 
manipulations were carried out as previously described [28,38,39]. The 
mutagenic primers used to substitute the mutated residues are shown in Table 
1. Presence of only the mutation expected in each case was confirmed by 
sequencing the complete cloned cDNA. The plasmid used as the template for 
mutagenesis experiments, containing the cDNA sequence coding for wild-type 
α-sarcin, has already been described [38,40]. 
 
Protein production and purification 
 
E. coli BL21 (DE3) cells cotransformed with a thioredoxin-producing 
plasmid (pT-Trx) and the corresponding α-sarcin mutant plasmids were used to 
produce the different proteins studied, as previously described [38,40,41]. 
Fungal wild-type α-sarcin was obtained as previously reported [28]. Protein 
purification included ion exchange and molecular exclusion chromatographies 
[28]. PAGE of proteins, Western blot immunodetection, protein hydrolysis, and 
amino acid analysis were performed according to standard procedures [38,41]. 
 
Spectroscopic characterization 
 
Absorbance measurements were performed on an Beckman DU640 
spectrophotometer at room temperature in cells with a 1 cm optical path length 
at a scanning speed of 240 nm/min. Circular dichroism (CD) spectra were 
obtained on a Jasco 715 spectropolarimeter, equipped with a thermostated cell 
holder and a NesLab-111 circulating water bath, at 0.2 nm/s. The instrument 
was calibrated with (+)-10-camphorsulfonic acid. CD spectra were recorded in 
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cylindrical cells with an optical path length of 0.1 and 1.0 cm. Mean residue 
weight ellipticity is expressed in units of deg cm2 dmol-1. Thermal denaturation 
profiles were obtained by measuring the temperature dependence of the 
ellipticity at 220 nm in the range 25–80ºC; the temperature was continuously 
changed at a rate of 0.5ºC/min. Fluorescence emission spectra were recorded 
on an SLM Aminco 8000 spectrofluorimeter at 25ºC using a slit width of 4 nm 
for both excitation and emission beams. The spectra were recorded for 
excitation at 275 and 295 nm and both were normalized by considering that Tyr 
emission above 380 nm is negligible. The Tyr contribution was calculated as the 
difference between the two normalized spectra. Thermostated cells with a path 
length of 0.2 and 1.0 cm for the excitation and emission beams, respectively, 
were used. The temperature was controlled using a circulating water bath. All 
these experiments were made with the proteins dissolved in 50 mM sodium 
phosphate, pH 7.0, containing 0.1 M NaCl following procedures described 
before [28,38]. 
 
Ribonucleolytic activity 
 
The ribonucleolytic activity of α-sarcin on eukaryotic ribosomes was 
followed by detecting the release of the near 400-nts α-fragment from a rabbit 
cell-free reticulocyte lysate. Production of this fragment was visualized by 
ethidium bromide staining after electrophoresis on denaturing 2.4% agarose 
gels. The specific cleavage by α-sarcin of an SRL-like synthetic 35-mer RNA 
was also studied. The synthesis of this SRL RNA was carried out as described 
[42]. The assay was performed with 4 µM SRL RNA and incubation for 15 min 
at 37ºC in 50 mM Tris-HCl buffer, pH 7.0, containing 0.1 M NaCl and 5 mM 
EDTA. The reaction products were detected by ethidium bromide staining after 
electrophoretic separation on a denaturing 19% (w/v) polyacrylamide gel. The 
specific action of α-sarcin produced 21- and 14-mer fragments. In addition, the 
activity of the purified proteins against homopolynucleotides (zymogram) was 
also assayed. Volumograms of the electrophoretic bands (based on integrating 
all of the pixel intensities comprising each spot) were obtained with the UVI-Tec 
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photo documentation system and UVIsoft UVI band Windows Application 
V97.04. These data were used to quantify the enzyme activity in the different 
assays. All these enzymatic assays were performed as previously described 
[28,38,42]. Convenient controls were routinely performed to test potential non-
specific degradation of the substrates, which did not occur under the conditions 
used. 
 
Phospholipid vesicle aggregation 
 
Dimyristoylphosphatidylglycerol (DMPG) was purchased from Avanti 
Polar Lipids Inc. (Alabaster, USA). Vesicles were formed by hydrating a dry lipid 
film with 15 mM Tris, pH 7.0 containing 0.1 M NaCl and 1 mM EDTA for 60 min 
at 37ºC. This lipid suspension was then subjected to five cycles of extrusion 
through two stacked 0.1-mm (pore diameter) polycarbonate membranes [33]. 
The average diameter of the vesicle population was 100 nm (85% of the 
vesicles in the range 75–125 nm), as determined by electron microscopy 
studies [33]. Aggregation was monitored as previously described [24,28] by 
measuring the increase in absorbance at 400 nm of a suspension of vesicles 
(30 mM final lipid concentration) after addition of a small aliquot of a freshly 
prepared solution of protein. 
 
Results 
 
Protein purification and structural characterization 
 
All six proteins, wild-type and the five single mutants, were purified to 
homogeneity and in milligram amounts (Table 2), according to their SDS-PAGE 
behavior (Fig. 2A) and amino acid composition. This composition was 
consistent with the mutations expected in each case. All them were also 
detected by a rabbit anti-α-sarcin serum in Western blot assays (Fig. 2B). The 
amino acid analysis and the corresponding UV-absorbance spectra were used 
to calculate their extinction coefficients (Table 2). 
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The native conformation of the wild-type protein was fully preserved in all 
the mutants, according to the coincidence of their far-UV circular dichroism 
spectra (Fig. 3A). The spectral features in the near-UV range (Fig. 3B) were 
also very similar with just the mutants showing small differences practically 
within the error range of this type of determination. Accordingly, fluorescence 
emission spectra for both wild-type and the five mutant proteins were also very 
similar (Fig. 4 and Table 2). These results again suggested that the wild-type 
protein conformation was retained in the mutants. 
All mutants studied showed a slightly decreased conformational stability 
in comparison with the wild-type protein (Fig. 5) according to their Tm values 
and the corresponding estimated Δ(ΔG) (Table 3). Apparently, substitution of 
Lys 21 rendered the most unstable mutant. However, the obtained low Δ(ΔG) 
values and the shape of the thermal denaturation profiles (Fig. 5) were also in 
agreement with the assumption that the mutant proteins displayed an overall 
conformation very similar to that of wild-type α-sarcin. 
 
Enzymatic characterization 
 
 All mutants studied displayed a slightly lower specific ribonucleolytic 
activity than wild type α-sarcin when assayed against intact ribosomes in a 
rabbit reticulocyte lysate (Fig. 6). However, all them behaved indistinguishable 
when assayed against less specific substrates such as an SRL-like 
oligonucleotide (Fig.7) or the hompolynucleotide poly(A) (Fig. 8). Unexpectedly, 
the α-sarcin K14E mutant was also able to cleave poly(C), an 
homopolynucleotide resistant to the action of the wild-type protein or the other 
mutants here studied (Fig. 8). 
 
Interaction with Phospholipid Vesicles 
 
In the present study the aggregation of DMPG vesicles promoted by the 
wild-type protein and the NH2-terminal β-hairpin mutants was followed by 
recording the increase of the apparent absorbance at 400 nm of a suspension 
9 
 
of DMPG vesicles after addition of a small aliquot of a freshly prepared protein 
(Fig. 9). The kinetic profiles of this phospholipid vesicles aggregation showed a 
biphasic behavior (Fig. 9) that was only observed at very low protein/lipid molar 
ratios for the wild-type α-sarcin and the K11E mutant, as expected from 
previous studies [33]. On the other hand, the other four mutants studied 
displayed a much different kinetic pattern of vesicle aggregation being the 
biphasic pattern much more evident, even at high protein/lipid molar ratios (Fig. 
9). These differences were especially significant for mutants K14E and K21E. 
Apparently, the first aggregation step would be the one being more affected by 
the mutations, as revealed by the net apparent absorbance change observed at 
shorted times (Fig. 10). Simultaneously, a delay in the onset of the formation of 
the structures appearing at longer times was also observed for mutants K14E, 
K21E, and R22E (Fig. 9), being again much more pronounced at the lower 
protein concentrations used. 
 
Discussion 
 
The SRL sequence and conformation is maintained in all ribosomes 
known so far. Furthermore, structural characterization of different SRL-like 
oligoribonucleotides has revealed how these isolated structures adopt the same 
conformation as well [43-45], being indeed susceptible of specific recognition 
and cleavage by ribotoxins [42,46]. The toxin and SRL structural determinants 
involved in their mutual recognition have been identified and characterized [13-
15,47]. However, this cleavage reaction against an isolated SRL-like RNA takes 
place at rates about 1000-fold slower than when using intact ribosomes [37,46] 
indicating that additional recognition elements are needed for the optimal 
ribotoxins’ inactivation action against ribosomes. The involvement of the 
ribosomal context in terms of electrostatic interactions has been suggested not 
only to justify this recognition and binding enhancement but also to explain the 
differences found when these toxins are assayed against ribosomes of different 
origins [18,37]. Electrostatic interactions involving the α-sarcin NH2-terminal-β-
hairpin have been also suggested to mediate α-sarcin specific recognition of 
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ribosomal proteins [18]. In fact, mutation of some basic residues that lie outside 
the restrictocin-SRL interface has been shown to decrease markedly the 
ribosomes cleaving rates without having any effect on the kinetics of assays 
employing an isolated SRL-like oligoribonucleotide [37]. It is also well proven 
how electrostatic interactions are needed for the establishment of the 
associations needed to allow the passage of ribotoxins across acid phospholipid 
membranes [24,25,27] and the α-sarcin NH2-terminal-β-hairpin is one of the 
protein regions that has been involved in this membrane recognition mechanism 
[23,48]. 
Ribotoxins are basic proteins with high pI values [1] due to their high 
content of basic residues mostly located at their unstructured loops [13-15]. Five 
of them concentrate at the α-sarcin NH2-terminal-β-hairpin being indeed 
residues 14, 17, 21, and 22 conserved among the different ribotoxins known, 
with the exception of hirsutellin A, a much smaller ribotoxin of recent 
characterization [12]. Therefore, with the aim of defining the role of electrostatic 
interactions involving α-sarcin NH2-terminal-β-hairpin, these five basic amino 
acid residues were mutated to Glu and their involvement in the molecular 
mechanism of α-sarcin cytotoxicity was studied.  
Structural characterization of the isolated purified proteins revealed that 
all retained the wild-type conformation, as indicated by their spectroscopic and 
thermodynamical characterization. Only minor changes were observed after 
inspection of the near-UV CD (Fig. 3) and fluorescence emission spectra (Fig. 
4), most probably due to the presence of Tyr 18 and 25 and Trp-4, a residue 
that dominates α-sarcin emission [49], within the sequence of the mutated NH2-
terminal-β-hairpin. All mutants were slightly less stable than the wild-type 
protein (Table 3) but the differences were even smaller than those ones found 
among the different natural ribotoxins known [12,48], in good agreement with 
previous results indicating that the NH2-terminal-β-hairpin folds as a rather 
independent structure with low influence on the global thermostability of the 
protein [23]. This observation is in good accordance with the fact that most of 
the residues mutated do not establish obvious interactions with any other amino 
acid of the protein globular core with perhaps the only exception of the non-
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conserved Lys 11 [15]. The highest difference was found for α-sarcin K21E, 
being the mutated Lys a residue involved in an electrostatic interaction with Glu-
19 [50], an interaction which is not possible for the mutant protein. 
Regarding their enzymatic characterization, it seems clear from the 
results presented that any charge reversion at the NH2-terminal-β-hairpin 
results in a diminished specific activity against intact ribosomes (Fig. 6) without 
affecting the less specific ribonucleolytic action of the protein (Fig. 7 and 8). Lys 
11 and 14 had been predicted before to establish electrostatic interactions with 
specific negative residues from ribosomal proteins [18]. The present results 
would not only confirm this prediction but also suggest that additional 
interactions are established between the positively charged side-chains at the 
NH2-terminal-β-hairpin and negatively charged ribosomal elements, not only 
proteins but most probably also rRNA included. The observation of the different 
specificity displayed by mutant K14E against homopolynucleotides (Fig. 8) 
reveals that the β-hairpin is also involved in their recognition. This involvement 
might be in terms of a direct interaction with the polymer or most probably due 
to a modification of the active site accessibility, as has been also suggested 
before [15,51]. In fact, these solvent accessibility changes were detected before 
upon deletion of the β-hairpin [22]. 
It is well known how α-sarcin interacts with lipid vesicles through 
electrostatic and hydrophobic interactions promoting events of vesicle 
aggregation that are followed by lipid mixing occurring between the bilayers of 
the aggregated vesicles, as would be expected for fusing liposomes 
[1,24,25,28]. Stopped-flow measurement of the initial rates of this aggregation 
induced by α-sarcin showed a second-order dependence on phospholipid 
concentration, suggesting the formation of vesicle dimers as the initial steps of 
the process [33]. These same experiments revealed that protein-protein 
interactions were involved in the establishment of the needed contacts to 
maintain the mentioned vesicle dimers [33]. In the present experiments the use 
of smaller protein concentrations revealed the existence of a biphasic behavior 
even at the much longer time scale of minutes used now (Fig. 9). Thus, the first 
step observed would correspond to the formation of small vesicles aggregates, 
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mostly stabilized by protein-protein and protein-vesicle interactions, which 
would later evolve during the second step of the process to much larger 
structures involving not only aggregation but also fusion events [24,25,33]. This 
mechanism would be fully compatible with the biphasic behavior observed in 
these experiments performed at lower protein/lipid molar ratios (Fig. 9) 
confirming the current model to explain the ability of ribotoxins to cross 
phospholipid membranes. Furthermore, the mutant showing more similar 
behavior to the wild-type protein was K11E, a protein where the mutated 
residue is not conserved among all ribotoxins, suggesting its minor contribution 
to the passage of the protein across the membranes. On the other hand, all the 
other four mutants studied showed a delay affecting the onset of the formation 
of small vesicle aggregates indicating their participation in maintaining the 
protein-protein and protein-vesicle interactions needed to initiate the 
aggregation process. The absence of a single positive charge seems to affect 
dramatically the accepted mechanism being this effect stronger for replacement 
of Lys residues 14 and 21. In fact, mutation of these two residues even impairs 
the formation of the larger aggregates according to the delay also observed for 
the second stage of the aggregation process. A similar behavior for the myelin 
basic protein has been attributed to the instability of the protein-protein 
interactions needed to aggregate the vesicles and most probably this would 
also be the case for these mutants. Overall, the lipid-protein interaction 
characterization suggest that residues Lys 14, Lys 17, Lys 21, and Arg 22 do 
participate directly in the first stages of the vesicle aggregation induced by α-
sarcin being much more determinant the role played by residues 14 and 21. 
In summary, the result presented show that electrostatic interactions 
established by the conserved positively charged residues of the α-sarcin NH2-
terminal-β-hairpin are essential not only for the correct specific recognition of 
the ribosome but also for the optimal establishment of the phospholipid 
interactions needed to cross the membranes of its presumed target cells.  
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Fig. 1. Diagrams showing the three dimensional structure of α-sarcin (A) and a 
detail of its NH2-terminal β-hairpin (B). The different basic residues mutated to 
Glu are shown. 
 
Fig. 2. Analysis by SDS-PAGE of wild-type (1), K11E (2), K14E (3), K17E (4), 
K21E (5), and R22E (6) versions of α-sarcin. (A) Coomassie Brilliant Blue 
staining (0.5 µg of protein/lane). (B) Western blot analysis using an anti-(α-
sarcin) polyclonal antibody (0.1 µg of protein/lane). 
 
Fig. 3. Circular dichroism spectra in the far (A) and near (B) UV regions, of wild-
type (●), K11E (○), K14E (●), K17E (∆), K21E (   ), and R22E (□) versions of α-
sarcin. Mean residue weight ellipticity, θMRW, is expressed in units of degrees x 
cm2 x dmol-1. 
 
Fig. 4. Fluorescence emission spectra of wild-type, K11E, K14E, K17E, K21E, 
and R22E versions of α-sarcin at 0.1 mg/ml protein concentration. Spectra 1 
were obtained for excitation at 275 nm. Spectra 2 (tryptophan contribution) were 
obtained for excitation at 295 nm and normalized at wavelengths above 380 
nm. Spectra 3 (tyrosine contribution) were calculated as the difference spectra 
(spectrum 1 - spectrum 2). Fluorescence emission is expressed as percentage 
considering the intensity at the wavelength of the emission maximum of the 
wild-type protein, for excitation at 275 nm, as 100. All of the spectra were 
recorded at 25 °C and pH 7.0. 
 
Fig. 5. Thermal denaturation profiles of wild-type (●), K11E (○), K14E (●), K17E 
(∆), K21E (   ), and R22E (□) versions of α-sarcin. The measurements were 
performed by continuously recording the mean residue weight ellipticity at 220 
nm (θMRW) expressed in units of degrees x cm2 x dmol-1. 
 
Fig. 6. Ribosome-inactivating activity assay of wild-type, K11E, K14E, K17E, 
K21E, and R22E versions of α-sarcin (Upper pannel). A control in the absence 
of enzyme is also shown (▬). The highly specific ribonucleolytic activity of the 
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ribotoxins is shown by the release of the 400-nt α-fragment (arrow) from the 
28S rRNA of eukaryotic ribosomes. Bands corresponding to 28S and 18S RNA 
are also indicated. Cell-free reticulocyte lysates were incubated in the presence 
of 100 ng of each protein. The reaction mixture was analyzed on 2.4% agarose 
gels and stained with ethidium bromide. Quantitation of these activities is also 
shown (lower panel), taking as unit the activity found for the wild-type protein in 
these conditions. 
 
Fig. 7. Activity assay on the 35mer oligonucleotide mimicking the SRL. This 
substrate was incubated in presence of wild-type, K11E, K14E, K17E, K21E, 
and R22E versions of α-sarcin (upper panel). A control in the absence of 
enzyme is also shown (▬). Two arrows indicate the position of the 21mer and 
14mer oligonucleotides resulting from the specific cleavage of a single 
phosphodiester bond. The intact 35-mer oligo is also shown. Quantitation of 
these activities is also shown (lower panel), taking as unit the activity found for 
the wild-type protein in these conditions. 
 
Fig. 8. Zymogram assay of the ribonucleolytic activity against poly(A) and 
poly(C) (upper and lower panels, respectively). These assays were made at pH 
7.0 employing 0.75 µg of wild-type, K11E, K14E, K17E, K21E, or R22E versions 
of α-sarcin. A control in the absence of enzyme is also shown (▬). 
 
Fig. 9. Kinetic measurement of the effect of the different α-sarcin versions 
studied on phospholipid vesicle aggregation. The phospholipid/protein molar 
ratios employed were: 333 (trace 1), 167 (trace 2), 111 (trace 3), 83 (trace 4), 
and 67 (trace 6). The concentration of DMPG used in these assays was 100 
μM.  
 
Fig. 10. The extent of phospholipid vesicles aggregation after 100s, 
corresponding to the first step of the process, is represented against the 
concentration employed of the different α-sarcin variants studied. The 
concentration of DMPG used in these assays was 100 μM. 
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Table 1. Mutagenic primers used to construct individual mutant versions of wild-
type α-sarcin where the NH2-terminal β-hairpin basic residues had been 
substituted by Asp. The bases that change original codon to Asp are 
underlined. 
α-sarcin mutant oligonucleotide sequence 
K11E 5’  ttg aac gac cag gag aac ccc aag acc  3’ 
K14E 5’  cag aag aac ccc gag acc aac  aag tat  3’   
K17E 5’  ccc aag acc aac gag tat gag acc aaa  3’ 
K21E 5’  aag tat gag acc gaa cgc ctc ctc tac  3’ 
R22E 5’  tat gag acc aaa gag ctc ctc tac aac  3’ 
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Table 2. Purification yields (mg per liter of original broth) and spectroscopic 
properties of the different proteins studied. 
 
Protein yield  E0.1% (280 nm, 1 cm) QTyra QTrpa 
WT 7.0 mg/lb 1.34 1.00 1.00 
K11E 10.5 mg/l 1.31 1.08 1.09 
K14E 17.0 mg/l 1.36 0.92 1.03 
K17E 12.5 mg/l 1.36 1.06 1.03 
K21E 12.5 mg/l 1.35 1.03 1.06 
R22E 12.0 mg/l 1.20 1.03 1.13 
a Relative quantum yield of Tyr and Trp referred to the values of the wild-type 
protein. 
b [41]. 
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Table 3. Thermodynamic parameters of the different mutants studied. 
 
Protein Tm (ºC) Δ(ΔG) (Kcal/mol)a 
WT 52.0 0.00 
K11E 47.0 -2.09 
K14E 48.1 -1.62 
K17E 48.1 -1.62 
K21E 40.9 -4.64 
R22E 47.3 -1.97 
aΔ(ΔG) = (ΔH × ΔTm/Tm) is the stability change produced by the mutation [ΔH, 
enthalpy change for the wild-type protein (136 Kcal/mol) determined at pH 7.0 
from differential scanning calorimetric measurements [52]; ΔTm = Tm (mutant) − 
Tm (wild-type); Tm, value obtained for the mutant variant] [53]. 










